TriLink BioTechnologies is a biotechnology company under Maravai LifeSciences, specializing in the synthesis and manufacturing of nucleic acid products. The company is renowned for its mRNA synthesis, clean capping technology, and custom nucleic acid chemistries. TriLink provides comprehensive services in mRNA development, including Discovery, GMP Manufacturing, and Analytical Services facilitating the development of nucleic acid therapies from research stages to commercial manufacturing. The company is a leader in synthesizing modified nucleotides and oligonucleotides, playing a crucial role in advancing numerous mRNA-based therapeutics, including vaccine development.